Health In Tech, Inc. (HIT)
Health In Tech, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Health In Tech, Inc. (HIT) is a Software - Application company based in US with a market capitalization of $54.9M. Revenue grew 71.0% year-over-year and free cash flow was negative at -$56.1K. This page tracks HIT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 73 employees · IPO Dec 23, 2024
Valuation
Valuation & price
$1.06 · as of May 17, 2026 · -71.9% vs 52w high
47.9
P/E ratio
Latest-FY diluted EPS
3.21
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$54.9M
Market cap
71.0%
Revenue growth (YoY)
62.8%
Gross margin
-$56.1K
Free cash flow (USD)
-$7.5M
Net debt
Net cash position
-16.7%
Share dilution
1/4
Graham criteria passed
Defensive-investor screen
Technology
Sector
Trajectory
Long-term trends
Revenue by year
2022 → 2025
Free cash flow by year
2022 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 14, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- FinancingSecurities RegistrationJun 26, 2026Filing
- FinancingSecurities RegistrationJun 10, 2026Filing
- FinancingSecurities RegistrationMay 22, 2026Filing
- 8-K eventEarnings ReleaseMay 14, 2026Filing
- Quarterly report10-Q FiledMay 14, 2026Filing
- 8-K eventEarnings ReleaseMay 13, 2026Filing
- 8-K eventInvestor PresentationMay 13, 2026Filing
- 8-K eventConsulting AgreementMay 1, 2026Filing
- FinancingSecurities RegistrationApr 24, 2026Filing
Questions
Frequently asked questions
What is Health In Tech, Inc.'s market cap?
Health In Tech, Inc. (HIT) has a market capitalization of $54.9M.
What is HIT's P/E ratio?
HIT trades at a price-to-earnings ratio of 47.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is HIT's price-to-book (P/B) ratio?
HIT trades at 3.21 times book value per share.
Are insiders buying HIT stock?
SEC Form 4 filings show no open-market insider buys at Health In Tech, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Software - Application
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.